Novo Nordisk's Wegovy reduces risk of serious heart problems by 20%, study shows
A study showing that Novo Nordisk's Wegovy has the ability to reduce the risk of serious heart problems in some patients by 20% was published in the New England Journal of Medicine.
FAA creates committee to address pilot mental health issues
The Federal Aviation Administration is developing a committee of aviation experts to help address any barriers that would prevent pilots from reporting mental health issues.
AstraZeneca raises stakes in obesity drug race with Eccogene deal
AstraZeneca said it had struck the deal for ECC5004, a once-daily oral drug that is part of a class of highly promising weight-loss medicines known as GLP-1 receptor agonists.
FDA eye drop warning: The products being recalled
Several eye care products were recalled after the Food and Drug Administration published a list of over two dozen products that could be contaminated with bacteria.
FDA approves Eli Lilly's tirzepatide for weight loss
Eli Lilly's drug tirzepatide was approved by the Food and Drug Administration to help people who are overweight and have a weight-related medical condition lose weight.
Amazon unveils One Medical health care benefit for Prime members for $9 a month
Amazon Prime members can now buy memberships to its One Medical health care service at a discounted rate, the e-commerce giant announced Wednesday.
Eye drop products: What consumers should know about the FDA's warning
Despite recent warnings from the FDA, experts say consumers shouldn't avoid all eye drop products. The agency says some could cause eye infections and potentially lead to vision loss.
Eye drops sold at Walmart added to FDA's list of potentially harmful products
The Food and Drug Administration warned Monday about another eye drop product that consumers should avoid due to the potential risk of an eye infection.
Pfizer quarterly results hit by soft demand for COVID-19 products
Sales of the company's coronavirus vaccine Comirnaty dropped 70% during the third quarter compared with the same period a year earlier, Pfizer reported on Tuesday.
Eye drops sold at CVS, Rite Aid, Target could cause eye infections and vision loss, FDA says
The Food and Drug Administration is warning consumers to avoid about two dozen eye drop products after discovering "insanitary conditions" in the manufacture's facility.
Pilots say they need to prioritize their mental health as pressures mount
Mental fitness in aviation should never be overlooked, pilots argue. It is something that needs to be focused on especially as pressures in the industry mount.
Over 70 sickened in multi-state salmonella outbreak tied to onions
A mutli-state outbreak of salmonella infections has already sickened over 70 people and sent at least 15 people to the hospital, according to federal health officials.
Eli Lilly, Novo Nordisk test popular weight loss-related drugs on children
Eli Lilly and Novo Nordisk are seeking to test some of their most popular drugs approved for Type 2 diabetes and weight management in adults on children.
What is phenylephrine and why is CVS pulling products containing it?
CVS was the first pharmacy to announce it was removing certain cold and flu products with phenylephrine even before the U.S. Food and Drug Administration made a final decision.
CVS pulls popular cold medicines from store shelves
CVS confirmed Thursday that it has voluntarily decided to remove certain medicines after an FDA panel had determined last month that their active ingredient is not effective.
Breast Cancer Awareness Month: Tennis great Martina Navratilova shares journey of her dual cancer battle
Martina Navratilova is a fierce and aggressive competitor, skills that became a crucial component to help her overcome the fight against Stage 1 throat and breast cancer.
Walgreens reveals its pick for new CEO
Walgreens Boots Alliance unveiled on Tuesday evening whom it has selected to lead the pharmacy store chain: former head of Cigna's Evernorth Tim Wentworth.
GSK settles 4 Zantac lawsuits claiming heartburn drug caused cancer
GSK announced Wednesday that it has settled four cases in California that were linked to its now-discontinued heartburn drug Zantac. The company didn't disclose a settlement figure.
Bristol Myers Squibb to buy cancer drugmaker Mirati Therapeutics in up to $5.8B deal
Bristol Myers Squibb will buy Mirati Therapeutics in a deal worth up to $5.8 billion, or $58 per share, the biopharmaceutical company announced Sunday.
Over 58,000 pounds of ground beef recalled due to E.coli concerns
More than 50,000 pounds of ground beef products were recalled after a sample tested positive for Shiga toxin-producing E. coli, commonly associated with foodborne outbreaks.

















